3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations

Therapeutic monoclonal antibodies (mAbs) are an emerging and very active frontier in clinical oncology, with hundred molecules currently in use or being tested. These treatments have already revolutionized clinical outcomes in both solid and hematological malignancies. However, identifying patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzzeloni, Virginia, Veschini, Lorenzo, Pedica, Federica, Ferrero, Elisabetta, Ferrarini, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326665/
https://www.ncbi.nlm.nih.gov/pubmed/35892706
http://dx.doi.org/10.3390/antib11030046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326665/
https://www.ncbi.nlm.nih.gov/pubmed/35892706
http://dx.doi.org/10.3390/antib11030046

Ejemplares similares